For the quarter ending 2026-03-31, IRWD made $106,506K in revenue. $40,773K in net income. Net profit margin of 38.28%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Total revenues | 106,506 | 47,709 | 122,060 | 85,239 |
| Research and development | 21,940 | 21,863 | 22,468 | 23,373 |
| Selling, general and administrative | 12,033 | 19,293 | 21,908 | 16,795 |
| Restructuring, net | -40 | -252 | 2,200 | -250 |
| Total costs and expenses | 33,933 | 40,904 | 46,576 | 39,918 |
| Income (loss) from operations | 72,573 | 6,805 | 75,484 | 45,321 |
| Interest expense and other financing costs | 9,141 | 7,886 | 8,434 | 8,356 |
| Interest and investment income | 1,698 | 1,459 | 930 | 818 |
| Other | 42 | 77 | 40 | 39 |
| Other income (expense), net | -7,401 | -6,350 | -7,464 | -7,499 |
| Income (loss) before income taxes | 65,172 | 455 | 68,020 | 37,822 |
| Income tax expense | 24,399 | 2,731 | 27,940 | 14,223 |
| Net income (gain) | 40,773 | -2,276 | 40,080 | 23,599 |
| Basic EPS | 0.25 | -0.014 | 0.25 | 0.15 |
| Diluted EPS | 0.24 | -0.017 | 0.23 | 0.14 |
| Basic Average Shares | 163,451,000 | 162,456,000 | 162,215,000 | 161,723,000 |
| Diluted Average Shares | 166,690,000 | 136,357,000 | 177,764,000 | 176,837,000 |
IRONWOOD PHARMACEUTICALS INC (IRWD)
IRONWOOD PHARMACEUTICALS INC (IRWD)